BioSante presents vaccine report
LINCOLNSHIRE - BioSante Pharmaceuticals Inc. will present a BioSante cancer vaccine portfolio update at the BIO International Convention, which will take place May 3-6 in Chicago. Stephen M. Simes, BioSante's president and CEO, will provide a status report on BioSante's portfolio of cancer vaccines in clinical development, as well as an update on LibiGel testosterone gel in clinical development for the treatment of female sexual dysfunction.
Article Comments
Guidelines: Keep it civil and on topic; no profanity, vulgarity, slurs or personal attacks. People who harass others or joke about tragedies will be blocked.
If a comment violates these standards or our terms of service, click the "flag" link in the lower-right corner of the comment box. To find our more, read our FAQ.